Examining the Durability of HIV Regimens

40 Years of Research from Ward 86 to Improve HIV CareПодробнее

The Evolution of HIV Infection to a Chronic Inflammatory DiseaseПодробнее

Progress in Developing an HIV Vaccine: Empiricism and a Bit of OptimismПодробнее

HIV Treatment Guidelines and Regimens: Review for Medical Case Managers WebinarПодробнее

Pharmacology - HIV antiretroviral drugs (classes, mechanism of action and side effects)Подробнее

IAS-USA Guidelines: Treatment of HIV December 2022 UpdatesПодробнее

IAS-USA HIV Treatment Guidelines: Review of the 2020 UpdateПодробнее

Webinar: Addressing HIV drug resistance to protect the effectiveness of HIV treatmentПодробнее

Overview of Newer and Upcoming Antivirals for HIV - Ep. 7Подробнее

Challenges and Opportunities in HIV ScienceПодробнее

Study reveals Cure for HIV AIDS | UPSC IAS | GS3 | StudyIQ IAS #UPSC #IAS #CSE #IPSПодробнее

Gaps in Research for Two-Drug HIV RegimensПодробнее

State of the Science: What We Know about Long-Acting Injectable Agents for Treatment of HIVПодробнее

Efficacy and Safety of the 2-Drug Regimen Dolutegravir/Lamivudine (DTG/3TC) in... - Cindy VavroПодробнее

Can You Get HIV through Touch? #shorts #medical #facts #hivПодробнее

Durable control of HIV infections in the absence of antiretroviral therapy: Opportunities and ...Подробнее

“Should I Tell My Nail Tech I Have HIV?” #curiousПодробнее

An End to AIDS? Breakthrough Study Finds HIV Treatment Eliminates Risk of Passing VirusПодробнее

Drug Options for the Complex HIV Patient - Daniel KuritzkesПодробнее

Fostemsavir (Rukobia): The How, Why, and When of Using this Novel Antiretroviral (ARV) to Treat HIVПодробнее